Tahereh (Zohre) Javaheri
Tahereh (Zohre) Javaheri
Verified email at bu.edu
Cited by
Cited by
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ...
The Lancet 396 (10258), 1223-1249, 2020
Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study
GA Roth, GA Mensah, CO Johnson, G Addolorato, E Ammirati, ...
Journal of the American College of Cardiology 76 (25), 2982-3021, 2020
Five insights from the global burden of disease study 2019
CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ...
The Lancet 396 (10258), 1135-1159, 2020
Tumor microenvironment complexity and therapeutic implications at a glance
R Baghban, L Roshangar, R Jahanban-Esfahlan, K Seidi, ...
Cell Communication and Signaling 18 (1), 1-19, 2020
JAK-STAT signaling in cancer: From cytokines to non-coding genome
J Pencik, HTT Pham, J Schmoellerl, T Javaheri, M Schlederer, Z Culig, ...
Cytokine 87, 26-36, 2016
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global …
GBDUHC Collaboration
The Lancet, 2020
STAT3 regulated ARF expression suppresses prostate cancer metastasis
J Pencik, M Schlederer, W Gruber, C Unger, SM Walker, A Chalaris, ...
Nature communications 6 (1), 1-15, 2015
Tumor target amplification: implications for nano drug delivery systems
K Seidi, HA Neubauer, R Moriggl, R Jahanban-Esfahlan, T Javaheri
Journal of controlled release 275, 142-161, 2018
Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model.
ÜA Minas TZ, Surdez D, Javaheri T, Tanaka M, Howarth M, Kang HJ, Han J, Han ...
Oncotarget, 2016
Association of the epithelial–mesenchymal transition (EMT) with cisplatin resistance
M Ashrafizadeh, A Zarrabi, K Hushmandi, M Kalantari, ...
International Journal of Molecular Sciences 21 (11), 4002, 2020
STAT5BN642H is a driver mutation for T cell neoplasia
HTT Pham, B Maurer, M Prchal-Murphy, R Grausenburger, ...
The Journal of clinical investigation 128 (1), 387-401, 2018
Tumor cell dormancy: threat or opportunity in the fight against cancer
R Jahanban-Esfahlan, K Seidi, MH Manjili, A Jahanban-Esfahlan, ...
Cancers 11 (8), 1207, 2019
Efficient conditional and promoter-specific in vivo expression of cDNAs of choice by taking advantage of recombinase-mediated cassette exchange using FlEx …
L Schebelle, C Wolf, C Stribl, T Javaheri, F Schnütgen, A Ettinger, Z Ivics, ...
Nucleic acids research 38 (9), e106-e106, 2010
NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth
NZTJ Khaled Seidi, Rana Jahanban-Esfahlan, Hassan Monhemi, Peyman Zare ...
Oncogene, 2018
Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3
AE Micah, Y Su, SD Bachmeier, A Chapin, IE Cogswell, SW Crosby, ...
The Lancet, 2020
CovidCTNet: an open-source deep learning approach to diagnose covid-19 using small cohort of CT images
T Javaheri, M Homayounfar, Z Amoozgar, R Reiazi, F Homayounieh, ...
npj Nature Digital Medicine 4 (1), 1-10, 2021
Horizontal gene transfer: from evolutionary flexibility to disease progression
M Emamalipour, K Seidi, S Zununi Vahed, A Jahanban-Esfahlan, ...
Frontiers in Cell and Developmental Biology 8, 229, 2020
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
Cell Death and Disease, 2016
YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model
TZ Minas, J Han, T Javaheri, SH Hong, M Schlederer, Y Saygideğer-Kont, ...
Oncotarget 6 (35), 37678, 2015
The system can't perform the operation now. Try again later.
Articles 1–20